Johnson & Johnson (JNJ) is acquiring Abiomed (ABMD) in a deal expected to close soon pending final conditions.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on STLD:
- Steel Dynamics to replace Abiomed in S&P 500 at open on 12/22
- Steel Dynamics Provides Fourth Quarter 2022 Earnings Guidance
- Steel Dynamics sees Q4 adjusted EPS $4.10-$4.14, consensus $3.84
- Steel Dynamics downgraded to Neutral from Buy at UBS
- U.S, EU weigh tariffs on Chinese steel, aluminum, Bloomberg says